Examkin

Soru

Zorluk: OrtaGeneral Internal Medicine

A 58-year-old female is admitted to the progressive care unit with worsening confusion, severe fatigue, abdominal pain, and polyuria over the past two weeks. She has a history of breast cancer treated with mastectomy and localized radiation five years ago. Vital signs show a blood pressure of 98/60 mm Hg and a heart rate of 110/min. Physical examination demonstrates dry mucous membranes and diminished skin turgor. Laboratory analysis reveals a serum calcium level of 14.8 mg/dL (normal: 8.4-10.2 mg/dL), a low parathyroid hormone level, and elevated parathyroid hormone-related peptide (PTHrP).

Arrange the following management steps in the most appropriate sequential order for this patient's acute severe hypercalcemia, from the immediate initial intervention to definitive long-term management.

  1. 1Initiate rapid intravenous normal saline infusion
  2. 2Administer subcutaneous or intramuscular calcitonin
  3. 3Administer an intravenous bisphosphonate (e.g., zoledronic acid)
  4. 4Initiate systemic antineoplastic therapy for recurrent malignancy

Cevap

The correct sequence is: 1) Initiate rapid intravenous normal saline infusion, 2) Administer subcutaneous or intramuscular calcitonin, 3) Administer an intravenous bisphosphonate, and 4) Initiate systemic antineoplastic therapy for recurrent malignancy.
The correct sequence respects the pharmacokinetics and physiological priorities of hypercalcemic crisis management. Intravascular volume must be restored first (saline). Once volume is addressed, rapid-acting agents (calcitonin) bridge the gap until delayed, long-acting agents (bisphosphonates) take effect. Finally, the underlying malignancy must be treated to prevent recurrence.

Adım Adım Çözüm

1
Address volume depletion.
Rapid intravenous normal saline expands intravascular volume.
Severe hypercalcemia causes nephrogenic diabetes insipidus, leading to profound dehydration. Restoring volume is the most critical first step to stabilize hemodynamics and improve renal calcium clearance.
2
Provide rapid-acting calcium reduction.
Administration of calcitonin lowers calcium within 4 to 6 hours.
Because definitive calcium-lowering medications take days to work, calcitonin is used immediately for rapid suppression of bone resorption.
3
Administer long-acting calcium reduction therapy.
Administration of an IV bisphosphonate provides sustained calcium control.
Bisphosphonates take 48-72 hours to reach full effect. Giving them early ensures they begin working precisely as calcitonin loses effectiveness (tachyphylaxis typically occurs after 48 hours).
4
Treat the root cause.
Systemic antineoplastic therapy addresses the source of PTHrP.
Symptomatic hypercalcemia of malignancy requires treating the underlying tumor to prevent long-term recurrence.

Anahtar Kavram

The algorithmic management of severe hypercalcemia (>14 mg/dL) relies on sequential intervention: initial volume resuscitation with isotonic saline, rapid short-term calcium reduction with calcitonin, sustained long-term calcium reduction with bisphosphonates, and definitive treatment of the underlying cause.
Bu soruyu puanla

Konular

General Internal Medicine

Bu konudan daha fazla soru